Metropolitan Life Insurance CO Sight Sciences, Inc. Transaction History

Metropolitan Life Insurance CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$8.44 - $13.35 $2,489 - $3,938	-295 Reduced 18.47%	1,302 $11,000
Q4 2022 Jun 14, 2023	BUY	$5.58 - $13.94 $1,646 - $4,112	295 Added 22.66%	1,597 $19.5 Million
Q4 2022 Mar 30, 2023	SELL	$5.58 - $13.94 $479 - $1,198	-86 Reduced 5.11%	1,597 $19,000
Q4 2022 Feb 15, 2023	BUY	$5.58 - $13.94 $8,911 - $22,262	1,597 New	1,597 $19,000
Q2 2022 Jun 20, 2023	BUY	$6.61 - $11.99 $2,518 - $4,568	381 Added 29.26%	1,683 $15,000
Q1 2022 Jun 20, 2023	BUY	$11.56 - $17.9 $4,404 - $6,819	381 Added 29.26%	1,683 $19,000
Q1 2022 Mar 30, 2023	SELL	$11.56 - $17.9 $21,975 - $34,027	-1,901 Reduced 53.04%	1,683 $19,000
Q1 2022 May 12, 2022	BUY	$11.56 - $17.9 $19,455 - $30,125	1,683 New	1,683 $19,000
Q4 2021 Feb 15, 2022	SELL	$17.36 - $27.36 $62,218 - $98,058	-3,584 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$22.34 - $39.1 $50,979 - $89,226	2,282 Added 175.27%	3,584 $81,000
Q3 2021 Mar 30, 2023	BUY	$22.34 - $39.1 $44,389 - $77,691	1,987 Added 124.42%	3,584 $81,000
Q3 2021 Nov 15, 2021	BUY	$22.34 - $39.1 $80,066 - $140,134	3,584 New	3,584 $81,000

21.4M

30.7K

18.6K

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $287M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.